Mercados españoles cerrados

Field Trip Health Ltd. (FTRP)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
0,85000,0000 (0,00%)
Al cierre: 04:00PM EDT
0,8700 +0,02 (+2,35%)
Después del cierre: 07:49PM EDT

Yahoo Finanzas España eliminará nuestros foros de Conversaciones el 15 de agosto. ¡Gracias por ser un miembro fiel de nuestra comunidad de Conversaciones de Finanzas!

Inicia sesión para publicar un mensaje.
  • V
    V
    Any ideas on what happened to $NUMI and $FTRP late afternoon. Both went up 7% after 1 pm with huge buy orders.
  • B
    Big Daddy Draper
    Wow. Double the amount of clinics than $FTRP and didn’t need a $95,000,000 dilutive raise. I’m impressed.

    https://ca.finance.yahoo.com/news/novamind-doubles-size-adds-four-120000147.html
  • V
    V
    Another red day in psychedelics. All my holdings $MMED, $CYBN, $HUGE, $CMPS and $FTRP are in the red today. 😢 I believe in the medicine. HODL.
  • O
    Oracle
    This is why you need to buy. Small minds are trying to get this lower for the sake of having the best possible average when Novamind has its first run.

    The CEO already stated $200,000,000 Revenue in 3 years.

    Novamind has revenue, Field Trip does not ( novaminds competitor/ closest comparison )

    NM’s financials that were just released not long ago were stellar. Unfortunately the news was overshadowed by a heavy bear market; the sentiment will catch up soon.

    The year over year growth, treatments administered, not to mention revenue, cripples Field Trip $FTRP, which is why I didn’t buy into Field Trip.

    Field trip will need to do a ton of more Dilution due to the Clinical side, where Novamind clearly stated they do not need to do what Field Trip is doing to produce even more share holder value ( ie, dilute for clinical trials and working with drug pipelines ).

    Novamind is working directly side by side with MAPS, and has the head honcho for Life Labs, arguably one of Canada’s largest clinical lab sites.

    Of course Chuck from Auxly is always good for a pump since that’s what he does best.

    If you’re wondering why the price isn’t moving it’s because it’s simply manipulated by Anonymous. Whenever I check L2 anon just sets walls up on the sell, preventing it from going up. The same thing happened with TRIP at $0.065 before it exploded to .70, anon for many weeks had big walls on the sell. This is the time to accumulate and get as many shares as possible

    Very undervalued, and I look at this manipulation as a blessing as I added to my position today to average down.

    This is 100% a buy. Plus WallStreetReporter literally only covers 10x-100x stocks so you know this puppy will moon this year at some point

    https://ceo.ca/nm?4e23f9321d71
  • N
    Nicky
    $FTRP.CN conversation
    Stifel GMP just gave $FTRP a price target of $8.50 CAD and $CYBN a price target of $5.00 CAD. Both SPECULATIVE BUY ratings. Big upside on both FTRP and CYBN from current price levels!
  • S
    Sam
    $FTRPF conversation
    STIFEL bullish on $FTRP and expects ~120% increase in share price with TSX up-listing!

    'FTRP announced the conditional approval to list its shares and warrants on the TSX, an up-listing from its current CSE position and the first psychedelics company to target the Canadian senior exchange, in our view. We view this positively given the potential for greater access to capital and improving liquidity. Shares/warrants are expected to be de-listed from the CSE to list on the TSX potentially this summer under the same tickers (FTRP & FTRP-WT). In addition, we believe this senior listing may be a stepping stone to reach a US exchange cross-listing, which could amplify current efforts and be reached late 2021. We note a peer increased its share price by ~120% at the peak and ~35% to-date with average trading volumes increasing ~9.5x through US cross-listing. While the TSX may be considered junior to a US exchange, we believe a similar momentum could be achieved for FTRP.'

    Source: STIFEL GMP Analyst Report May 27th 2021
  • B
    Bobby Axelrod
    $FTRP.TO conversation
    $FTRP up 20% in the last 24 hours. Let's go!!!
  • T
    T Crown
    Highly undervalued here. This is close to other names like $NUMI $CYBN $FTRP which means $TRYP should be $3+
  • R
    Roaring Kitty
    Omg talk about a WIN having partnership with BIG PHARMA

    https://ca.finance.yahoo.com/news/novamind-partners-merck-treatment-resistant-120000323.html

    omg talk about a market cap 1/4 the size of $FTRP for a company with MORE REVENUE and MORE GROWTH.

    omg the revenue from the Merck clinical trials will be substantial

    omg Yaron the CEO said “$200,000,00 revenue in 3 years” - its now even more clear how that will be achieved now that BIG PHARMA is involved with Novamind

    O...m...g....is it just a coincidence a short decided to log into an account they barely use just to insult the company who’s company COO Pierre Bou-Mansour just publicly filed his recent insider buy ( Feb 18,2021) at $1.71 CAD ( above current share price ). Shorts will come out now because they know $NM is making BIG moves ( see Merck ) and they know they have to cover soon.

    https://ceo.ca/api/sedi?insider=&symbol=NM&date=&transaction=&amount=&undefined[company_symbol]=NM

    With such a small float, this will catch up to $FTRP.

    This is HIGHLY undervalued ( insiders buying at $1.71 confirms that ) so buy now BEFORE the major liquidity arrives and you miss the easy 1-200% gains like the rest of the shroom stocks.
  • B
    Big Daddy Draper
    Craig doing a “friendly reminder” to longs. Creates an account to make one comment on the Novamind board. What a 🤡 lol

    You should be willing to hold any stock for minimum 2 years.

    NM has more revenue than $FTRP, at a fraction the market cap. More revenue than Mind Med. more revenue than NUMI. Its the ONLY clinic that got partnered with big pharma.

    So Craig, you made an account to make one message on this board. And failed. Lol
  • V
    V
    Looks like a whale came in and bought psychedelics pre-market. $MMED, $FTRP, $CYBN, $HUGE and $SEEL all up 3 - 5% pre-market today.
  • W
    Wizard
    It’s waking up. Will have the same SP as $FTRP soon. More revenue than Field Trip...extremely undervalued.
  • T
    Tom
    $FTRP.CN conversation
    $FTRP $FTRPF seems to be the only stock in green today in the psychedelic sector.
  • V
    V
    FIeld Trip gets NASDAQ approval. $FTRP They Should be on NASDAQ by end of July!
  • B
    Big Daddy Draper
    The best part about Nova is their track record. The year over year growth is incredible. The revenue is up 100% year over year for the past 2 years. Amount of treatments have increased by the thousand percentiles. Incredible growth. Low float. Undervalued MAJORLY compared to $FTRP. And 33.9% insider ownership
  • O
    Oracle
    $NM.CN conversation
    Have been watching for a few weeks. Will be making an entry tomorow if it dips any further.

    seems like an excellent company who already has millions in revenue... Really not sure why this isn't priced like $FTRP.
  • B
    Big Daddy Draper
    Lots of support at 1.55.

    Looks like it could start a reversal finally.
    Lots of positive talk on Reddit about how Novamind is undervalued and how it will catch up to $FTRP soon. I agree. It has millions in revenue, field Trip doesnt.
  • V
    V
    Excited for the ETF tomorrow! $FTRP is going to take off 🚀$FTRP should benefit the most from this ETF because of their relatively low trading volume. Even a slight increase in trading volume because of the ETF would move their share price significantly!! 🚀🚀🚀🚀🚀
  • W
    Wizard
    Lol can you make your short position any more obvious.

    Common sense people. All small caps/shroom stocks are down. And this rat is trying to paint a picture of it being personal against Novamind, and acting like investors “caught on” to it being a long play hahaha

    Looks better on paper than $FTRP, which is why I’m STILL accumulating. That’s why I always win.

    https://ceo.ca/nm?5fff309702c4